A study of the complete response rate with a combination of high dose cytarabine and cladribine in refractory and relapsed acute leukemia

International Journal of Hematology-Oncology and Stem Cell Research

Volumn 4, Issue 1, 2010, Pages 5-8

  Nodehi, Reza Safaei ^a   Gharib, Behrouz ^a   Sharifian, Ramazaali ^a   Emami, Amirhossein ^a   Moghadaszadeh, Majid ^b   Sardashti, Sara ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acute leukemia; Chemotherapy regimen; Mortality

Indexed keywords

CLADRIBINE; CYTARABINE; GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ALOPECIA; ARTICLE; BLAST CELL; BLEEDING; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG MEGADOSE; DRUG RESPONSE; FEMALE; HUMAN; HUMAN TISSUE; INFECTION; IRAN; LEUKEMIA RELAPSE; LEUKOCYTE COUNT; LIVER TOXICITY; MALE; MORTALITY; MUCOSA INFLAMMATION; NAUSEA AND VOMITING; NEPHROTOXICITY; NEUROTOXICITY;

EID: 79952405705     PISSN: 17351243     EISSN: 20082207     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Atra A, Gerrard M, Hobson R, et al. Outcome of Relapsed or Refractory Childhood B-cell Acute Lymphoblastic Leukemia and B-cell non-Hodgkin's Lymphoma Treated with the UKCCSG 9003/9002 Protocols. Br J Haematol, 2001; 112: 965-968.
2. Pastore D, Specchia G, Carluccio P, et al. FLAG-IDA in the Treatment of Refractory/Relapsed Adult Acute Myeloid Leukemia: Single Center Experience. Ann Hematol, 2003; 82: 231-235.
3. Camera A, Annino L, Chiurazzi F, et al. GIMEMA ALLrescue 97: A Salvage Strategy for Primary Refractory or Relapsed Adult Acute Lymphoblastic Leukemia. Haematologica 2004; 89: 145-153.
4. Robak T, Wrzesien-Kus A. The Search for Optimal Treatment in Relapsed and Refractory Acute Myeloid Leukemia. Leuk Lymph, 2002; 43: 281-291.
5. Specchia G, Pastore D, Carluccio P, et al. FLAG-IDA in the Treatment of Refractory/Relapsed Adult Acute Lymphoblastic Leukemia. Ann Hematol, 2005; 84: 792-795.
6. Wrzesien-Kus A, Robak T, Lech-Maranda E. A Multicenter, Open, non-Comarative, Phase II Study of the Combination of Cladribine (2-Chlorodeoxyadenosine), Cytarabine, and G-CSF as Induction Therapy in Refractory Acute Myeloid Leukemia-areport of the Polish Adult Leukemia Group (PALG). Eur J Hematol, 2003; 71 (3): 155-162.